ARIAD PHARMACEUTICALS INC 4
4 · ARIAD PHARMACEUTICALS INC · Filed Feb 3, 2016
Insider Transaction Report
Form 4
LAVIDAS ATHANESE
Director
Transactions
- Award
Common Stock
2016-02-01+12,500→ 131,631 total - Award
Stock Option (Right to Buy)
2016-02-01$4.91/sh+25,000$122,750→ 25,000 totalExp: 2026-02-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock options vest as to one-fourth of the options on each of March 31, 2016, June 30, 2016, September 30, 2016, and December 31, 2016.